Melissa West

PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models

Helen Y. Zou, Luc Friboulet, David P. Kodack et al. · Cancer Cell · 2015 · 456 citations · Full text

Drug Target, Health Sciences, Preclinical Models +10

PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations

Helen Y. Zou, Qiuhua Li, Lars D. Engstrom et al. · Proceedings of the National Academy of Sciences · 2015 · 267 citations · Full text

Inhibitory Activity, Radiation Oncology, Fusion Kinases +14

RECOGNIZING DINOFLAGELLATE SPECIES USING ITS rDNA SEQUENCES¹

R. Wayne Litaker, Mark W. Vandersea, Steven R. Kibler et al. · Journal of Phycology · 2007 · 186 citations

Genetics, Taxonomy, Rdna Sequences +17

Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots.

James X. Chen, Yi Zheng, Melissa West et al. · PubMed · 1998 · 148 citations

Chromatin, Genome Instability, Mutational Hot Spots +13

Method for gene replacement in Pseudomonas aeruginosa used in construction of recA mutants: recA-independent instability of alginate production

Dennis E. Ohman, Melissa West, JoAnne L. Flynn et al. · Journal of Bacteriology · 1985 · 55 citations · Full text

Engineering, Genetics, Bacteriology +17